Immuno Cancer Biotherapeutics, Inc. funding
Immuno Cancer Biotherapeutics, Inc., a biotechnology company based in Canton, SD (founded 2024), filed a Form D with the SEC on October 15, 2026 and reported $75K raised.
Amount raised$75K
Offering sizeOpen-ended
Filed with the SECOctober 15, 2026
First saleOctober 9, 2026
IndustryBiotechnology
SecuritiesOther
LocationCanton, SD
Founded2024
Entity typeCorporation
Investors so far3
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Oct 15